Mental Health May Predict Pain Levels After Breast Cancer Treatment

A common lingering challenge of breast cancer treatment might be linked to past trauma, underscoring the need to address mental and physical health.

7:00 AM

Author | Hannah Schweitzer

Image of woman wearing green infront of pink background wearing breast cancer pin

 

About a quarter of women treated for breast cancer experience moderate to severe pain for many years after their treatment ends. Sometimes, there's no obvious reason why.

"Are there people, before cancer therapy, who are more likely to develop chronic pain later?" asks Ellen M. Lavoie Smith, Ph.D., a researcher at the University of Michigan Rogel Cancer Center and associate professor in the School of Nursing.

To understand this better, Smith and colleagues recruited women before their breast cancer surgery and had them complete surveys. The team followed those women for a year after treatment, asking participants to report their pain.

The goal: to find factors that may influence pain severity.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

The women self-reported their pain severity, including whether the pain interfered with daily functions. Women also reported their levels of anx­iety, fatigue, sleep/wake disturbance, cognitive difficulty and whether they had experienced any childhood trauma.

Researchers also assessed "pain catastrophizing" — in other words, how much each woman described her symptoms as profoundly horrible.

Examining personal history, attitudes

A woman's mental health plays a significant role in her recovery. Past exposure to trauma could influence pain severity after cancer treatment, U-M researchers found.

In addition, patients who rate high on pain catastrophizing are more likely to develop more severe and chronic pain. The study also found a woman's beliefs in her ability to control pain had an impact on her pain.

MORE FROM MICHIGAN: Subscribe to our weekly newsletter       

"Some people believe that you have no control: If you develop something terrible, you must have done something to bring that about yourself," Smith says. "They believe external factors or chance, rather than oneself, controls pain.

"The people with those beliefs are more likely to have poorly controlled pain."

These three predictors affect both chronic pain and acute pain, such as pain in the area of surgery.

Addressing mental health early

Patients rarely are asked about their mental health and mindset when they come in for cancer therapy. Smith wonders if practitioners should start asking.

She says that it may be important to ask the patient about prior trauma exposure and their thoughts and attitudes about pain before starting treatment.

"Certainly, there's nothing we can do to prevent trauma exposure," Smith says. "But if we know someone has been exposed to trauma, then we could potentially do something now that might protect them from pain after their treatment."

SEE ALSO: Treating Nerve Pain After Chemotherapy: An Option That Works

Some potential approaches include earlier assessment and proactive nursing interventions before and during breast cancer treatment. Those efforts, Smith notes, may lead to significant decreases in post-treatment chronic pain, a complex problem with few effective interven­tions.

For example, patients might benefit from cognitive behavioral therapy before cancer treatment as a way to better process their thoughts about pain and managing that pain.

Recognizing chronic pain

Smith hopes that cancer patients and their providers recognize that chronic pain is real, whether or not the source is obvious, and that there are things they can do to control that pain.

"Even if you think there really shouldn't be pain because there's no obvious injury to the body, remember that the cause of pain may not be obvious when due to changes that have occurred in the brain," she says, "and that many factors beyond just tissue injury will affect pain severity."

For more information about treating pain related to breast cancer, call the Cancer AnswerLine at 800-865-1125.


More Articles About: Cancer Care Rogel Cancer Center Breast cancer Breast Cancer Treatment Mental Health Assessment Hospitals & Centers
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories outline drawing of pancreas on beige screen with green orange yellow and pink
Health Lab
Avoiding recovery delays with hospitalized pancreatitis
Acute pancreatitis is among the most common gastrointestinal conditions requiring inpatient hospital care in the United States. Balancing the signaling of the interleukin-22 protein and interleukin-22 binding protein is crucial to recovery from acute and chronic pancreatitis.
Cancer Aware
Focal therapy for prostate cancer
When treating for localized prostate cancer, surgery and radiation are usually what people hear about. However, there are other treatments that could be options under a heading of focal therapy. Dr. Andrew Wood, a urologic oncologist with U-M Health Rogel Cancer Center’s Weiser Center for Prostate Cancer talks about these options and which patients could benefit from them.
pill being taken close up with water near hand
Health Lab
Patients are opting in for 10 years of breast cancer treatment
As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a recent study sheds light on whether patients are opting for it.
cells spikey on pink background purple spikes
Health Lab
New clinical trials for pediatric brain tumors
Brain and spinal cord tumors account for one in four childhood cancers. Although 75% of children survive for at least five years after being diagnosed, many patients have recurrent tumors that cannot be cured. Andrea Franson discusses current therapies for pediatric brain tumors, how viruses can be used to target tumor cells and the new phase 1 trial that started in May 2025.
cells purple some lighter cells in white
Health Lab
Researchers find early driver of prostate cancer aggressiveness
University of Michigan Health Rogel Cancer Center scientists identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an existing class of drugs, suggesting a potential treatment strategy for patients with aggressive subtypes of prostate cancer.
cancer cell drawing in blue ink on off white background with floating yellow dots two of them
Health Lab
Researchers engineer a herpes virus to turn on T cells for immunotherapy
The University of Michigan team identified herpesvirus saimiri, which infects the T cells of squirrel monkeys, as a source of proteins that activate pathways in T cells that are needed to promote T cell survival.